Completed NA INTERVENTIONAL 2-arm NCT03110393

Ambu®AuraGain™ Versus I-gel® in Obese Patients

Prospective Randomized Comparison Between a Fiber Optic Intubation Via the Ambu® AuraGain ™ or the i-Gel® Laryngeal Mask Until a Complete Airway Protection in Obese Patients

Sponsor: Schulthess Klinik

Conditions Obese

Interventions Ambu AuraGain Intersurgical i-gel

Updated 7 times since 2017 Last updated: Jan 5, 2018 Started: Apr 20, 2017 Primary completion: Sep 6, 2017 Completion: Sep 6, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03110393, this NA trial focuses on Obese and remains completed. Sponsored by Schulthess Klinik, it has been updated 7 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

▶ Show 2 earlier versions

Oct 2017 — Jun 2018 [monthly]

Completed NA

Status: Recruiting → Completed
May 2017 — Oct 2017 [monthly]

Recruiting NA

First recorded

Apr 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Schulthess Klinik

Data source: Schulthess Klinik

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Zurich, Switzerland